These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6808665)

  • 1. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction.
    Michelassi F; Landa L; Hill RD; Lowenstein E; Watkins WD; Petkau AJ; Zapol WM
    Science; 1982 Aug; 217(4562):841-3. PubMed ID: 6808665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Mediators in Atherosclerotic Vascular Remodeling.
    Evans BR; Yerly A; van der Vorst EPC; Baumgartner I; Bernhard SM; Schindewolf M; Döring Y
    Front Cardiovasc Med; 2022; 9():868934. PubMed ID: 35600479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene receptors as potential therapeutic targets.
    Yokomizo T; Nakamura M; Shimizu T
    J Clin Invest; 2018 Jul; 128(7):2691-2701. PubMed ID: 29757196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Kounis syndrome after a hornet sting and literature review.
    Ralapanawa DM; Kularatne SA
    BMC Res Notes; 2014 Dec; 7():867. PubMed ID: 25465208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirubin-3'-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration.
    Blazevic T; Schaible AM; Weinhäupl K; Schachner D; Nikels F; Weinigel C; Barz D; Atanasov AG; Pergola C; Werz O; Dirsch VM; Heiss EH
    Cardiovasc Res; 2014 Mar; 101(3):522-32. PubMed ID: 24368834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function.
    Dannull J; Schneider T; Lee WT; de Rosa N; Tyler DS; Pruitt SK
    Blood; 2012 Mar; 119(13):3113-22. PubMed ID: 22323449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease.
    Sen CK; Rink C; Khanna S
    J Am Coll Nutr; 2010 Jun; 29(3 Suppl):314S-323S. PubMed ID: 20823491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.
    Rink C; Khanna S
    Antioxid Redox Signal; 2011 May; 14(10):1889-903. PubMed ID: 20673202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.
    Spanbroek R; Grabner R; Lotzer K; Hildner M; Urbach A; Ruhling K; Moos MP; Kaiser B; Cohnert TU; Wahlers T; Zieske A; Plenz G; Robenek H; Salbach P; Kuhn H; Radmark O; Samuelsson B; Habenicht AJ
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1238-43. PubMed ID: 12552108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene receptors.
    Dahlén SE
    Clin Rev Allergy Immunol; 1999; 17(1-2):179-91. PubMed ID: 10436865
    [No Abstract]   [Full Text] [Related]  

  • 12. Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit.
    Sala A; Rossoni G; Buccellati C; Berti F; Folco G; Maclouf J
    Br J Pharmacol; 1993 Nov; 110(3):1206-12. PubMed ID: 8298810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis.
    Aehringhaus U; Peskar BA; Wittenberg HR; Wölbling RH
    Br J Pharmacol; 1983 Sep; 80(1):73-80. PubMed ID: 6689134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations.
    Chang J; Skowronek MD; Cherney ML; Lewis AJ
    Inflammation; 1984 Jun; 8(2):143-55. PubMed ID: 6430801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.
    Flynn PJ; Becker WK; Vercellotti GM; Weisdorf DJ; Craddock PR; Hammerschmidt DE; Lillehei RC; Jacob HS
    Inflammation; 1984 Mar; 8(1):33-44. PubMed ID: 6325343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
    Lewis RA; Austen KF
    J Clin Invest; 1984 Apr; 73(4):889-97. PubMed ID: 6323538
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of leukotriene formation in pulmonary and vascular tissue.
    Lefer AM; Roth DM; Lefer DJ; Smith JB
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):186-9. PubMed ID: 6089002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction.
    Evers AS; Murphree S; Saffitz JE; Jakschik BA; Needleman P
    J Clin Invest; 1985 Mar; 75(3):992-9. PubMed ID: 3980734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eicosanoids and phospholipases].
    Goerig M; Habenicht AJ; Schettler G
    Klin Wochenschr; 1985 Apr; 63(7):293-311. PubMed ID: 3923251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molsidomine on cardiovascular leukotriene D4 actions.
    Fiedler VB; Abram TS
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):152-7. PubMed ID: 3839292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.